WonBiogen Co (307280.KQ) Stock Price

WonBiogen Co Price

CLOSED
5,500.00
​
Market closed

Revenue has compounded at 18.8% per year over the past 4 years to 35.24 B KRW. Earnings per share have grown at 26.7% per year over the last 3 years. WonBiogen Co's net margin stands at 18.8%, up from -4.0% several years earlier. WonBiogen Co currently offers a dividend yield of about 2.55%. The payout ratio is around 15% of earnings. The dividend has grown at 40.9% per year over the past 3 years.

WonBiogen Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

WonBiogen Co business model & stock analysis

WonBiogen Co Ltd, based in Gumi, South Korea, operates in the Health Care sector, focusing on the research and development of biocompatible medical materials. The company, listed on 5 December 2018, provides medical products such as wound dressings for lower leg ulcers, pressure ulcers, and surgical wounds, as well as absorbent dressings and fixation bands for bandages and catheters.

Frequently asked questions about WonBiogen Co

5 analysts currently rate the WonBiogen Co stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the WonBiogen Co share trades at 3.69 EUR (5,500.00 KRW).

The revenue cannot currently be calculated for WonBiogen Co.

The profit cannot currently be calculated for WonBiogen Co.

The P/E ratio cannot be calculated for WonBiogen Co at the moment.

The P/S cannot be calculated for WonBiogen Co currently.

The Eulerpool Quality Score for WonBiogen Co is 7/10.

The ISIN of WonBiogen Co is KR7307280008. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of WonBiogen Co is 307280.KQ. The ticker symbol is used to trade WonBiogen Co shares on the stock exchange.

Fair ValueTerminal
4,510.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Dec 5, 2018
ISIN
KR7307280008
Cusip
Y507AQ108
Market capitalization
39.02 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
—
P/S
P/Se
—
EV/EBIT
4.76
P/B Ratio
0.91
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
15.48 %
Dividend
Dividend yield
2.55 %
Est. Dividend Yield
3.05 %
Payout Ratio
15.01 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
4 years
Dividend not reduced since
4 years
Dividend increased since
1 year
Dividend withholding tax
22.00 %
Last updated Oct 31, 2026, 5:42 PM

WonBiogen Co Peer Group

WonBiogen Co FIGI

307280:KS · BBG00MCFZXP6307280:KQ · BBG00MCFZXR4

All fundamentals and in-depth analysis of WonBiogen Co

Our stock analysis for WonBiogen Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of WonBiogen Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.